1
|
Langdon RL, DiSabella MT, Strelzik JA. Screen time and pediatric headache: A scoping review of the literature. Headache 2024; 64:211-225. [PMID: 38299747 DOI: 10.1111/head.14674] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2023] [Revised: 12/08/2023] [Accepted: 12/13/2023] [Indexed: 02/02/2024]
Abstract
OBJECTIVE The aim of this study was to summarize the evidence regarding screen use as a contributing factor in pediatric headache and migraine. BACKGROUND Screen exposure is often reported as a headache trigger, though there is no current consensus in terms of how screen type, duration, or frequency influences pediatric headache and the associated burden of disease. METHODS A systematic search in PubMed, Scopus, Cochrane Library, ProQuest Health and Medical Database, and Google Scholar was performed through November 2022 in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. All English-language articles of pediatric patients aged ≤18 years evaluating screen use in relation to headache were included. RESULTS A total of 48 studies were included. Nearly all studies were cross-sectional and represented international samples. The strongest association between screen use and headache found was for duration of use, and computer use emerged as the most common device type related to headache. While there were mixed findings related to screen use and specific headache diagnosis, migraine appeared to confer a higher risk. Across studies, there were insufficient data to assess the impact of screen use on headache frequency or headache-related disability. Several studies demonstrated changes in screen use and headache patterns related to the COVID-19 pandemic and computer vision syndrome was commonly reported. CONCLUSIONS While there is preliminary evidence supporting possible associations between screen use and pediatric headache, there are several limitations in the present review including a lack of prospective and randomized controlled trials to better demonstrate causal relationships as well as methodological limitations with significant variability in how both headache and screen use are defined and measured. Future studies including real-time screen use and device monitoring are needed to better understand the influence of screen use behaviors on pediatric headache and to help further define best-use guidelines around these technologies.
Collapse
Affiliation(s)
- Raquel L Langdon
- Department of Neurology, Children's National Hospital, Washington, DC, USA
| | - Marc T DiSabella
- Department of Neurology, Children's National Hospital, Washington, DC, USA
| | - Jeffrey A Strelzik
- Department of Neurology, Children's National Hospital, Washington, DC, USA
| |
Collapse
|
2
|
Yoon SY, Kim HM, Yi YY. The impact of the COVID-19 pandemic era on children with primary headache: a questionnaire survey study and literature review. Front Pediatr 2023; 11:1179979. [PMID: 37492607 PMCID: PMC10364439 DOI: 10.3389/fped.2023.1179979] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/05/2023] [Accepted: 06/26/2023] [Indexed: 07/27/2023] Open
Abstract
Background The coronavirus disease (COVID-19) pandemic has resulted in individual isolation and secondary problems, especially in children. Research on the effect of the social isolation on children with primary headache is limited. This study aimed at exploring the effects of environmental changes caused by COVID-19 on headache in children. Methods This cross-sectional survey study enrolled school-aged children (age, 8-16 years) with headache who were able to complete the questionnaire from a Pediatric Headache Clinic between January 2021 and December 2022. Headache diaries for all patients were in their medical records and two questionnaire responses were requested at a 3-month interval. The questionnaires included headache type, frequency, previous medical conditions, family history, Pediatric Migraine Disability Assessment scores (PedMIDAS) scores, changes in daily life after COVID-19, and factors that aggravated headaches associated with social distancing. Results We identified 35 patients who were diagnosed with primary headache and continued to visit our outpatient clinic for at least 3 months. Among them, 33 (15 males and 18 females) patients responded to the first survey. The average age (±SD) of patients was 12.5 ± 1.9 years. PedMIDAS scores were not affected by the COVID-19 infection history. Prolonged use of masks and increased use of digital devices were reported as the most common factors that aggravated headache during the pandemic era. Conclusion COVID-19 did not affect in worsening primary headache in children. However, the pandemic can introduce various changes in daily life, which in turn can affect the management of headache. By gathering feedback regarding the thoughts of the patients on the impact of the current pandemic environment, patient counseling on the precautions and management can be conducted in advance in the case of repeated lockdown in the future.
Collapse
Affiliation(s)
- So Yeon Yoon
- Department of Pediatrics, Hallym University and Kangdong Sacred Heart Hospital, Seoul, Republic of Korea
| | - Hye Min Kim
- Department of Pediatrics, Hallym University and Kangdong Sacred Heart Hospital, Seoul, Republic of Korea
| | - Yoon Young Yi
- Department of Pediatrics, Hallym University and Kangdong Sacred Heart Hospital, Seoul, Republic of Korea
- Department of Pediatrics, College of Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Republic of Korea
| |
Collapse
|
3
|
Katsuki M, Matsumori Y, Kawahara J, Yamagishi C, Koh A, Kawamura S, Kashiwagi K, Kito T, Oguri M, Mizuno S, Nakamura K, Hayakawa K, Ohta O, Kubota N, Nakamura H, Aoyama J, Yamazaki I, Mizusawa S, Ueki Y, Ikeda T, Yamagishi F. School-based online survey on chronic headache, migraine, and medication-overuse headache prevalence among children and adolescents in Japanese one city - Itoigawa Benizuwaigani study. Clin Neurol Neurosurg 2023; 226:107610. [PMID: 36724587 DOI: 10.1016/j.clineuro.2023.107610] [Citation(s) in RCA: 11] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2022] [Revised: 12/02/2022] [Accepted: 01/01/2023] [Indexed: 01/22/2023]
Abstract
BACKGROUND We investigated the prevalence of headache, migraine, and medication-overuse headache (MOH) among children and adolescents through a school-based online questionnaire. We also investigated the triggers for migraine among them and the effect of the COVID-19 pandemic on headache frequency. METHODS Children and adolescents aged 6-17 y.o. completed an online questionnaire. Migraine, MOH was defined as The International Classification of Headache Disorders Third edition. Factor and clustering analyses were performed for migraine triggers. The effect of the coronavirus disease 2019 (COVID-19) pandemic on headache frequency was also asked. RESULTS Of the 2489 respondents, the prevalence of headache, migraine, and MOH were 36.44%, 9.48%, and 0.44%, respectively. Up to 70% of the respondents with headaches complained of the disturbance to daily life, but about 30% consulted doctors. The migraine triggers were grouped into 5 factors by factor analysis. The sensitivities of the migraineurs against the factors were divided into 3 clusters. Cluster 1 had stronger sensitivity for several triggers. Cluster 2 was sensitive to weather, smartphones, and video games. Cluster 3 had less sensitivity for triggers. Cluster 2 less consulted doctors even though the burden of migraine was enormous. During the COVID-19 pandemic, 10.25% of respondents increased headache attacks, while 3.97% decreased. CONCLUSIONS This is the first detailed study on headache prevalence in Japanese students from elementary school to high school in one region. The burden of headaches is large among children and adolescents, and the unmet needs of its clinical practice should be corrected.
Collapse
Affiliation(s)
- Masahito Katsuki
- Department of Neurosurgery, Itoigawa General Hospital, Itoigawa, Niigata 941-0006, Japan.
| | | | - Junko Kawahara
- Department of Health Promotion, Itoigawa City, Itoigawa, Niigata 941-8501, Japan
| | - Chinami Yamagishi
- Department of Health Promotion, Itoigawa City, Itoigawa, Niigata 941-8501, Japan
| | - Akihito Koh
- Department of Neurosurgery, Itoigawa General Hospital, Itoigawa, Niigata 941-0006, Japan
| | - Shin Kawamura
- Department of Neurosurgery, Itoigawa General Hospital, Itoigawa, Niigata 941-0006, Japan
| | - Kenta Kashiwagi
- Department of Neurology, Itoigawa General Hospital, Itoigawa, Niigata 941-0006, Japan
| | - Tomohiro Kito
- Department of Neurosurgery, Nou National Health Insurance Clinic, Itoigawa, Niigata 949-1331, Japan
| | - Masato Oguri
- Department of Pediatrics, Itoigawa General Hospital, Itoigawa, Niigata 941-0006, Japan
| | - Shoji Mizuno
- Department of Pediatrics, Itoigawa General Hospital, Itoigawa, Niigata 941-0006, Japan
| | - Kentaro Nakamura
- Department of Pediatrics, Itoigawa General Hospital, Itoigawa, Niigata 941-0006, Japan
| | | | - Osamu Ohta
- Itoigawa High School, Itoigawa, Niigata 941-0047, Japan
| | - Noa Kubota
- Itoigawa High School, Itoigawa, Niigata 941-0047, Japan
| | - Hina Nakamura
- Itoigawa High School, Itoigawa, Niigata 941-0047, Japan
| | - Jun Aoyama
- Itoigawa Hakurei High School, Itoigawa, Niigata 941-0063, Japan
| | | | - Satoshi Mizusawa
- Board of Education, Itoigawa City, Itoigawa, Niigata 941-8501, Japan
| | - Yasuhide Ueki
- Board of Education, Itoigawa City, Itoigawa, Niigata 941-8501, Japan
| | - Takashi Ikeda
- Department of Health Promotion, Itoigawa City, Itoigawa, Niigata 941-8501, Japan
| | - Fuminori Yamagishi
- Department of Surgery, Itoigawa General Hospital, Itoigawa, Niigata 941-0006, Japan
| |
Collapse
|
4
|
Ackley E, Gibler RC, Orr SL, Powers SW. Virtual issue: Recent advances in pediatric headache: Bridging the data gap. Headache 2023; 63:305-306. [PMID: 36651608 DOI: 10.1111/head.14468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2022] [Accepted: 11/23/2022] [Indexed: 01/19/2023]
Affiliation(s)
- Elizabeth Ackley
- Department of Child Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA
- Department of Child Neurology, Children's Hospital of Colorado, Aurora, Colorado, USA
| | - Robert C Gibler
- Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
| | - Serena L Orr
- Department of Pediatrics, Community Health Sciences, University of Calgary, Calgary, Alberta, Canada
- Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Scott W Powers
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
- Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital, Cincinnati, Ohio, USA
- Headache Center, Cincinnati Children's Hospital, Cincinnati, Ohio, USA
| |
Collapse
|
5
|
Checchi MP, Tarantino S, Ursitti F, Monte G, Moavero R, Sforza G, Ferilli MAN, Grimaldi Capitello T, Vigevano F, Valeriani M, Papetti L. Long-Term Effects of COVID-19 Pandemic on Migraine in Adolescents. A Retrospective Analysis of the Population Attending the Headache Center in Different Phases of the Pandemic. Brain Sci 2023; 13:brainsci13020273. [PMID: 36831817 PMCID: PMC9953965 DOI: 10.3390/brainsci13020273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2023] [Revised: 01/27/2023] [Accepted: 02/03/2023] [Indexed: 02/10/2023] Open
Abstract
BACKGROUND Literature data report that the first COVID-19 pandemic had an impact on the progression of migraine both in adults and children. The present study aimed to verify how the migraine course and psychological aspects varied in adolescent patients in relation to some of the different phases of the COVID-19 pandemic and compared with the months before COVID-19. In addition, the relationship between the characteristics of headache episodes and psychological and school-related aspects were analyzed. METHODS The study included 418 adolescents. Based on the timing of the evaluation, they were categorized into patients observed before the COVID-19 pandemic (pre COVID) or during the first (COVID 1) or second (COVID 2) wave of the pandemic. Subjects were also categorized into three further groups: those who had high or low frequency of migraine attacks during the month, those who had mild or severe pain during the attack, and those who were taking prophylactic drugs. The Patient Health Questionnaire-9 (PHQ-9) and General Anxiety Disorder-7 (GAD-7) scales were utilized to assess depression and anxiety. RESULTS We observed a significant increase in the frequency of attacks and the use of prophylactic drugs during the COVID 2 period compared to the COVID 1 and pre-COVID periods (p < 0.05). Patients showed higher levels of anxiety and depression during each of the two COVID periods compared with the pre-COVID months (p < 0.05), especially during the COVID 2 period (p < 0.05). CONCLUSION Our results show long-term negative impacts of the COVID-19 pandemic on clinical parameters and psychological symptoms in adolescents with migraine.
Collapse
Affiliation(s)
| | - Samuela Tarantino
- Developmental Neurology, Bambino Gesù Children Hospital, IRCCS, 00165 Rome, Italy
| | - Fabiana Ursitti
- Developmental Neurology, Bambino Gesù Children Hospital, IRCCS, 00165 Rome, Italy
| | - Gabriele Monte
- Developmental Neurology, Bambino Gesù Children Hospital, IRCCS, 00165 Rome, Italy
| | - Romina Moavero
- Developmental Neurology, Bambino Gesù Children Hospital, IRCCS, 00165 Rome, Italy
- Child Neurology and Psychiatry Unit, Tor Vergata University of Rome, 9220 Rome, Italy
| | - Giorgia Sforza
- Developmental Neurology, Bambino Gesù Children Hospital, IRCCS, 00165 Rome, Italy
| | | | | | - Federico Vigevano
- Neurological Sciences and Rehabilitation Medicine, Bambino Gesù Children Hospital, IRCCS, 00165 Rome, Italy
| | - Massimiliano Valeriani
- Developmental Neurology, Bambino Gesù Children Hospital, IRCCS, 00165 Rome, Italy
- Center for Sensory-Motor Interaction, Aalborg University, 9220 Aalborg, Denmark
| | - Laura Papetti
- Developmental Neurology, Bambino Gesù Children Hospital, IRCCS, 00165 Rome, Italy
- Correspondence: ; Tel.: +39-0668592865
| |
Collapse
|